The Long Run with Luke Timmerman cover image

Ep97: John Evans on Base Edited Therapeutics

The Long Run with Luke Timmerman

00:00

Selgine Deal - Why It Was So Important?

Agios was going after cancer metabolism. So this was finding new targets, and then we were going to drug them from scratch. And i think if we hadn't been able to do that kind of a selgine deal, where that amount of capital came in early, we would have just had to be much more narrow in our focus. You knowyou take two or three targets and you develop some drugs, and you hope for the best. But with the sel gine deal, and it was great that they shared this vision, we suddenly had the capital go after a much bigger pool of targets"

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app